BioNxt Solutions Statistics

Total Valuation

BioNxt Solutions has a market cap or net worth of CAD 47.63 million. The enterprise value is 53.16 million.

Market Cap	47.63M
Enterprise Value	53.16M

Important Dates

The next estimated earnings date is Tuesday, April 22, 2025.

Earnings Date	Apr 22, 2025
Ex-Dividend Date	n/a

Share Statistics

BioNxt Solutions has 113.40 million shares outstanding. The number of shares has increased by 14.30% in one year.

Current Share Class	n/a
Shares Outstanding	113.40M
Shares Change (YoY)	+14.30%
Shares Change (QoQ)	+2.98%
Owned by Insiders (%)	6.03%
Owned by Institutions (%)	n/a
Float	106.56M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-8.21
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-15.96

Financial Position

The company has a current ratio of 0.04

Current Ratio	0.04
Quick Ratio	0.02
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-1.69
Interest Coverage	-5.43

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-255.97%
Return on Capital (ROIC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.03
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -43.66% in the last 52 weeks. The beta is 0.53, so BioNxt Solutions's price volatility has been lower than the market average.

Beta (5Y)	0.53
52-Week Price Change	-43.66%
50-Day Moving Average	0.32
200-Day Moving Average	0.30
Relative Strength Index (RSI)	63.12
Average Volume (20 Days)	112,473

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BioNxt Solutions had revenue of CAD 42,008 and -6.48 million in losses. Loss per share was -0.06.

Revenue	42,008
Gross Profit	42,008
Operating Income	-5.35M
Pretax Income	-6.48M
Net Income	-6.48M
EBITDA	-5.27M
EBIT	-5.35M
Loss Per Share	-0.06

Full Income Statement

Balance Sheet

The company has 80,057 in cash and 5.61 million in debt, giving a net cash position of -5.53 million or -0.05 per share.

Cash & Cash Equivalents	80,057
Total Debt	5.61M
Net Cash	-5.53M
Net Cash Per Share	-0.05
Equity (Book Value)	-7.39M
Book Value Per Share	-0.07
Working Capital	-7.82M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -3.25 million and capital expenditures -84,319, giving a free cash flow of -3.33 million.

Operating Cash Flow	-3.25M
Capital Expenditures	-84,319
Free Cash Flow	-3.33M
FCF Per Share	-0.03

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-12,733.89%
Pretax Margin	-15,422.18%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BioNxt Solutions does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-14.30%
Shareholder Yield	-14.30%
Earnings Yield	-14.09%
FCF Yield	-6.99%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BioNxt Solutions has an Altman Z-Score of -159.51. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-159.51
Piotroski F-Score	n/a